Velan Capital Investment Management LP Heron Therapeutics, Inc. Transaction History
Velan Capital Investment Management LP
- $48.3 Million
- Q3 2024
A detailed history of Velan Capital Investment Management LP transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Velan Capital Investment Management LP holds 6,986,744 shares of HRTX stock, worth $11.2 Million. This represents 28.8% of its overall portfolio holdings.
Number of Shares
6,986,744
Previous 6,986,744
-0.0%
Holding current value
$11.2 Million
Previous $24.5 Million
43.14%
% of portfolio
28.8%
Previous 58.47%
Shares
3 transactions
Others Institutions Holding HRTX
# of Institutions
179Shares Held
121MCall Options Held
80.4KPut Options Held
94.9K-
Rubric Capital Management LP New York, NY26.7MShares$42.7 Million1.48% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.85MShares$14.2 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.72MShares$14 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$13.3 Million0.0% of portfolio
-
Tejara Capital LTD London, X05.31MShares$8.49 Million5.03% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $190M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...